α -synuclein conformational antibodies fused to penetratin are effective in models of Lewy body disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
α
-synuclein conformational antibodies fused to penetratin are effective in models of Lewy body disease
Authors
Keywords
-
Journal
Annals of Clinical and Translational Neurology
Volume 3, Issue 8, Pages 588-606
Publisher
Wiley
Online
2016-06-17
DOI
10.1002/acn3.321
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane
- (2015) El-Sayed Khafagy et al. AAPS Journal
- Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases
- (2015) Stephanie M. Williams et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy
- (2015) Markus Mandler et al. Molecular Neurodegeneration
- Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology
- (2015) Nishant N. Vaikath et al. NEUROBIOLOGY OF DISEASE
- Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson’s Disease
- (2015) Md Shahaduzzaman et al. PLoS One
- Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo
- (2015) Sofie Stalmans et al. PLoS One
- Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials
- (2014) Markus Mandler et al. ACTA NEUROPATHOLOGICA
- A Sensitive phage-based capture ELISA for sub-femtomolar detection of protein variants directly from biological samples
- (2014) Stephanie Williams et al. BIOTECHNOLOGY PROGRESS
- Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo
- (2014) Edward Rockenstein et al. BRAIN
- Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models
- (2014) D. Games et al. JOURNAL OF NEUROSCIENCE
- Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5 – implications for dementia with Lewy bodies
- (2014) Cassia R Overk et al. Molecular Neurodegeneration
- ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo
- (2014) Brian Spencer et al. MOLECULAR THERAPY
- Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice
- (2014) Veronica Lindström et al. NEUROBIOLOGY OF DISEASE
- α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration
- (2014) Hien T. Tran et al. Cell Reports
- Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice
- (2013) Nolwen L. Rey et al. ACTA NEUROPATHOLOGICA
- Axonopathy in an α-Synuclein Transgenic Model of Lewy Body Disease Is Associated with Extensive Accumulation of C-Terminal–Truncated α-Synuclein
- (2013) Dora Games et al. AMERICAN JOURNAL OF PATHOLOGY
- Caudo-rostral brain spreading of α-synuclein through vagal connections
- (2013) Ayse Ulusoy et al. EMBO Molecular Medicine
- Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies
- (2013) Stefan Schildknecht et al. JOURNAL OF NEUROCHEMISTRY
- Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other Synucleinopathies
- (2013) Adrien W. Schmid et al. MOLECULAR & CELLULAR PROTEOMICS
- Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
- (2013) Elvira Valera et al. PHARMACOLOGY & THERAPEUTICS
- TOM40 Mediates Mitochondrial Dysfunction Induced by α-Synuclein Accumulation in Parkinson’s Disease
- (2013) Andreas Bender et al. PLoS One
- Recombinant Single-Chain Antibody with the Trojan Peptide Penetratin Positioned in the Linker Region Enables Cargo Transfer Across the Blood–Brain Barrier
- (2012) Nives Škrlj et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- scFv Antibody: Principles and Clinical Application
- (2012) Zuhaida Asra Ahmad et al. Clinical & Developmental Immunology
- Cognitive deficits in a mouse model of pre-manifest Parkinson’s disease
- (2012) Iddo Magen et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Extracellular Alpha-Synuclein Oligomers Modulate Synaptic Transmission and Impair LTP Via NMDA-Receptor Activation
- (2012) M. J. Diogenes et al. JOURNAL OF NEUROSCIENCE
- Antibody-Aided Clearance of Extracellular -Synuclein Prevents Cell-to-Cell Aggregate Transmission
- (2012) E.-J. Bae et al. JOURNAL OF NEUROSCIENCE
- Lentivirus Mediated Delivery of Neurosin Promotes Clearance of Wild-type α-Synuclein and Reduces the Pathology in an α-Synuclein Model of LBD
- (2012) Brian Spencer et al. MOLECULAR THERAPY
- Prion-like acceleration of a synucleinopathy in a transgenic mouse model
- (2011) Anne-Laure Mougenot et al. NEUROBIOLOGY OF AGING
- Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
- (2011) Eliezer Masliah et al. PLoS One
- In vivo demonstration that -synuclein oligomers are toxic
- (2011) B. Winner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neurodegeneration in a Transgenic Mouse Model of Multiple System Atrophy Is Associated with Altered Expression of Oligodendroglial-Derived Neurotrophic Factors
- (2010) K. Ubhi et al. JOURNAL OF NEUROSCIENCE
- Alterations in mGluR5 Expression and Signaling in Lewy Body Disease and in Transgenic Models of Alpha-Synucleinopathy – Implications for Excitotoxicity
- (2010) Diana L. Price et al. PLoS One
- Detecting Morphologically Distinct Oligomeric Forms of α-Synuclein
- (2009) Sharareh Emadi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson’s disease by disturbing calcium flux
- (2009) Roberta Marongiu et al. JOURNAL OF NEUROCHEMISTRY
- Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in -Synuclein Models of Parkinson's and Lewy Body Diseases
- (2009) B. Spencer et al. JOURNAL OF NEUROSCIENCE
- The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice
- (2009) Valentine Bouet et al. Nature Protocols
- Intracellular targeting and clearance of oligomeric alpha-synuclein alleviates toxicity in mammalian cells
- (2009) Bin Yuan et al. NEUROSCIENCE LETTERS
- Inclusion formation and neuronal cell death through neuron-to-neuron transmission of -synuclein
- (2009) P. Desplats et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
- (2008) Jia-Yi Li et al. NATURE MEDICINE
- Formation of Toxic Oligomeric α-Synuclein Species in Living Cells
- (2008) Tiago Fleming Outeiro et al. PLoS One
- Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
- (2008) Igor F. Tsigelny et al. PLoS One
- An scFv Intrabody against the Nonamyloid Component of α-Synuclein Reduces Intracellular Aggregation and Toxicity
- (2007) Sandra M. Lynch et al. JOURNAL OF MOLECULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search